✦ LIBER ✦

Conversion From Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients With Gastrointestinal Tract Disorders

✍ Scribed by P. Darji; R. Vijayaraghavan; C.M. Thiagarajan; R.K. Sharma; B. Subbarao; R. Pishardy; K.V. Dakshinamurthy; R. Vijaykumar; G. Abraham; S. Bhaskar; L. Agarwal; B. Shah; A. Abraham; M. John; K. Sampathkumar; T. Das; L. Umesh; S. Sundar; H. Ballal; S. Jasuja; S. Saxena; T.K. Saha

Book ID: 116934539
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 342 KB
Volume: 40
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2008.07.041

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enteric-coated mycophenolate sodium: saf

Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients

✍ K Budde; P Glander; F Diekmann; D Dragun; J Waiser; L Fritsche; H.-H Neumayer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Renal Transplant Patients With Gastroint

Renal Transplant Patients With Gastrointestinal Intolerability to Mycophenolate Mofetil: Conversion to Enteric-Coated Mycophenolate Sodium

✍ N. Calvo; A.I. Sanchez-Fructuoso; J. Conesa; A. Moreno; A. Barrientos 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Quality of Life in Renal Transplant Reci

Quality of Life in Renal Transplant Recipients Following Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium

✍ F. Cofan; E. Rosich; M. Arias; V. Torregrosa; F. Oppenheimer; J.M. Campistol 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Reduction of Gastrointestinal Complicati

Reduction of Gastrointestinal Complications in Renal Graft Recipients after Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium

✍ P. Reinke; K. Budde; C. Hugo; P. Petersen; P. Schnuelle; L. Fricke; D. Scholz; H 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 513 KB

Safety Assessment of the Conversion From

Safety Assessment of the Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Stable Renal Transplant Recipients

✍ P. Massari; V. Duro-Garcia; F. Girón; E. Hernández; F. Juárez; C. Castro; M. Tol 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Conversion from mycophenolate mofetil to

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: A pilot study

✍ Jérôme Dumortier; Marie-Claude Gagnieu; Janine Salandre; Olivier Guillaud; Phili 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Gastrointestinal (GI) disorders are one of the main adverse events in patients treated by mycophenolic acid (MPA). The aim of this prospective study was to evaluate the effect of conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) in liver transplant patients